Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 34kWORD 16k
15 September 2021
E-003385/2021(ASW)
Answer given by Ms Gabriel
on behalf of the European Commission
Question reference: E-003385/2021

EU funding to the Wuhan Institute of Virology has been allocated under two projects(1) supporting the European Virus Archive EVA-global network. The funding contribution to the Institute does not cover any research activities.

It covers only the provision to European researchers of non-infectious human serology samples (antibodies), which relate to human immune responses to viral pathogens(2), and do not concern COVID-19 causative Severe Acute Respiratory Syndrome Coronavirus 2.

All services and (non-infectious) materials provided by the Wuhan Institute of Virology under these grants are duly recorded and accounted for at consortium level and are, therefore, subject to regular project monitoring by the Commission.

This regular project monitoring has not given so far rise to suspicion of non-compliance with rules applicable to Union funding; thus no reviews and audits targeting specifically this participant of the consortium have been implemented.

This is without prejudice to any future checks, reviews, audits and investigations that are possible under the grant agreement not just by the Commission but also the European Court of Auditors or the European Anti-Fraud Office (OLAF).

All activities carried out under these projects have been subject to ethics screening by the Commission and received clearance, based on the information provided by the consortium about ethics review and security procedures implemented by the consortium members as well as by the national authorisations provided to the participating laboratories.

(1)Grant agreements: https://cordis.europa.eu/project/id/653316 ; https://cordis.europa.eu/project/id/871029
(2)such as Severe Fever with Thrombocytopenia Syndrome Virus, Crimean-Congo Haemorrhagic Fever and Nipah.
Last updated: 22 September 2021Legal notice - Privacy policy